Buy, Sell or Hold: Windtree Therapeutics Inc (WINT-Q)

Windtree Therapeutics Inc (WINT-Q)

0.00

0.00 (0.00%) 1d

COMMENT

Chart indicates that it went back to visit the $1.50 level and was supported and went up from that point. It will probably have resistance at around the $2.40 level. The next point of resistance would be around $3.80.

Showing 1 to 1 of 1 entries

Windtree Therapeutics Inc(WINT-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Windtree Therapeutics Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Windtree Therapeutics Inc(WINT-Q) Frequently Asked Questions

What is Windtree Therapeutics Inc stock symbol?

Windtree Therapeutics Inc is a OTC stock, trading under the symbol WINT-Q on the (). It is usually referred to as or WINT-Q

Is Windtree Therapeutics Inc a buy or a sell?

In the last year, there was no coverage of Windtree Therapeutics Inc published on Stockchase.

Is Windtree Therapeutics Inc a good investment or a top pick?

Windtree Therapeutics Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Windtree Therapeutics Inc.

Why is Windtree Therapeutics Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Windtree Therapeutics Inc worth watching?

In the last year 0 stock analysts on Stockchase covered Windtree Therapeutics Inc. The stock is worth watching.

What is Windtree Therapeutics Inc stock price?

On , Windtree Therapeutics Inc (WINT-Q) stock closed at a price of $.

Most Recent Experts

Daniel Straus

National Bank Financial

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.